Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study

Shi, TY; Jiang, R; Pu, H; Yang, HJ; Tu, DS; Dai, ZY; Cai, YL; Zhang, YQ; Cheng, X; Jia, HX; Tu, RQ; Wang, HY; Tang, J; Luan, YT; Cai, SM; Zang, RY

Zang, RY (reprint author), Fudan Univ, Zhongshan Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol,Ovarian Canc Program, Shanghai, Peoples R China.

BRITISH JOURNAL OF CANCER, 2019; 121 (5): 425

Abstract

Dose-dense early postoperative intraperitoneal chemotherapy (DD-EPIC) significantly increased non-progression rate in advanced ovarian cancer (OC) pat......

Full Text Link